Stock analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
NASDAQ:ATHX opened at $0.00 on Tuesday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The company has a market capitalization of $191,328.90, a P/E ratio of 0.00 and a beta of -0.90.
About Athersys
Recommended Stories
- Five stocks we like better than Athersys
- 3 Tickers Leading a Meme Stock Revival
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- Options Trading – Understanding Strike Price
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- 3 REITs to Buy and Hold for the Long Term
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.